CAROLINE FRANZESE: Open Payments
NPI 1801529698 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$743 in 19 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $24 · 2025 $743
Food & beverage: $743
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $295 |
| ABBVIE INC. | 1 | $104 |
| Amgen Inc. | 4 | $98 |
| Novartis Pharmaceuticals Corporation | 3 | $87 |
| LEO Pharma Inc. | 3 | $66 |
| Organon LLC | 1 | $34 |
| Verrica Pharmaceuticals Inc. | 1 | $22 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $21 |
| Lilly USA, LLC | 1 | $16 |
Products named: TREMFYA, SKYRIZI, OTEZLA, ADBRY, Rhapsido, ANZUPGO, COSENTYX, YCANTH.
Industry payments across IN — which companies pay providers there.
